Kestra Medical Technologies (KMTS) had its price target lowered by The Goldman Sachs Group, Inc. from $22.00 to $17.00. They now have a "neutral" rating on the stock.
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner [Yahoo! Finance]
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
Kestra Medical Technologies (KMTS) had its "buy" rating reaffirmed by BTIG Research. They now have a $32.00 price target on the stock.
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock [Globe and Mail, The (Toronto, Canada)]